Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06225193 · ClinicalTrials.gov registry record
Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population
A clinical trial of Fatty Liver, sponsored by Methodist Health System.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT06225193 is a study of Fatty Liver that is actively recruiting participants, run by Methodist Health System. The registered enrollment target is 300 participants, above the 196-participant average among 20 other Fatty Liver trials with a reported enrollment target (53% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06225193, a study of Fatty Liver, is actively recruiting participants, sponsored by Methodist Health System.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
In this initial investigator-initiated retrospective study, aim to analyze the enhanced liver fibrosis (ELF) scores in this high-risk population for NAFLD/nonalcoholic steatohepatitis(NASH)-related fibrosis. Study define 'high-risk' to include metabolic syndrome, which can be further defined by an atherosclerotic cardiovascular disease (ASCVD) score \>7.5, any diagnosis of hyperlipidemia, history of coronary artery disease, history of heart failure, hypertension and/or type 2 diabetes. Study would also like to compare the performance of this score with historical methods of fibrosis assessment, where applicable, including vibration-controlled transient elastography, magnetic resonance elastography, blood markers and liver biopsy. Study will assess the impact of ELF scores on predicting liver events in the time, have used it and determine if diet, lifestyle changes and/or pharmacotherapy will improve serial ELF scores. Will also seek to understand how ELF scores are distributed in our community.
Conditions Studied
Study Locations (1)
Texas
- Methodist Dallas Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2023-06-20 |
| Est. Completion | 2026-06-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06225193
The ClinicalTrials.gov registry entry for NCT06225193 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 196-participant average among 20 other Fatty Liver trials with a reported enrollment target (53% higher). The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fatty Liver appearing as the primary indexed condition, and to 0 interventions.
NCT06225193 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06225193 about?
NCT06225193 is a clinical study titled "Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population". In this initial investigator-initiated retrospective study, aim to analyze the enhanced liver fibrosis (ELF) scores in this high-risk population for NAFLD/nonalcoholic steatohepatitis(NASH)-related fibrosis. Study define 'high-risk' to include metabolic syndrome, which can be further defined by an a...
What is the current status of trial NCT06225193?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2023-06-20. Estimated completion is 2026-06-23.
What conditions does trial NCT06225193 study?
This clinical trial studies the following conditions: Fatty Liver.
Who is sponsoring clinical trial NCT06225193?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06225193 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fatty Liver
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intermittent Fasting for NAFLD in Adults
RECRUITING · NA
-
Early Tracking of Childhood Health Determinants (ETCHED) Study
RECRUITING
-
Blood Collection Biorepository for Liver Disease Research
RECRUITING
-
Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis
ACTIVE NOT RECRUITING · Phase 2
-
Liver Positron Emission Tomography (PET) Study of Non Alcoholic Fatty Liver Disease
COMPLETED · Early Phase 1
-
Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC)
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.